Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cognitive Strategies in Early Psychosis 1
NCT07231497Phase 3Recruiting
- Sponsor
- University of Minnesota
- Start
- Oct 2025
- Primary completion
- Apr 2030
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of modafinil in schizophrenia, psychotic disorders, sponsored by University of Minnesota. Started Oct 2025; status: recruiting.
02
Drugs
modafinil
03
Conditions
schizophreniapsychotic disorders
Beyond the preview
Go deeper on NCT07231497.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07231497.